» Articles » PMID: 35762231

OCT4 Activates a Suv39h1-repressive Antisense LncRNA to Couple Histone H3 Lysine 9 Methylation to Pluripotency

Abstract

Histone H3 Lysine 9 (H3K9) methylation, a characteristic mark of heterochromatin, is progressively implemented during development to contribute to cell fate restriction as differentiation proceeds. Accordingly, in undifferentiated and pluripotent mouse Embryonic Stem (ES) cells the global levels of H3K9 methylation are rather low and increase only upon differentiation. How global H3K9 methylation levels are coupled with the loss of pluripotency remains largely unknown. Here, we identify SUV39H1, a major H3K9 di- and tri-methylase, as an indirect target of the pluripotency network of Transcription Factors (TFs). We find that pluripotency TFs, principally OCT4, activate the expression of Suv39h1as, an antisense long non-coding RNA to Suv39h1. In turn, Suv39h1as downregulates Suv39h1 transcription in cis via a mechanism involving the modulation of the chromatin status of the locus. The targeted deletion of the Suv39h1as promoter region triggers increased SUV39H1 expression and H3K9me2 and H3K9me3 levels, affecting all heterochromatic regions, particularly peri-centromeric major satellites and retrotransposons. This increase in heterochromatinization efficiency leads to accelerated and more efficient commitment into differentiation. We report, therefore, a simple genetic circuitry coupling the genetic control of pluripotency with the global efficiency of H3K9 methylation associated with a major cell fate restriction, the irreversible loss of pluripotency.

Citing Articles

H3K9 post-translational modifications regulate epiblast/primitive endoderm specification in rabbit blastocysts.

Bouchereau W, Pham H, Samruan W, Vu V, Joly T, Afanassieff M Epigenetics Chromatin. 2025; 18(1):2.

PMID: 39800758 PMC: 11727677. DOI: 10.1186/s13072-025-00568-8.


Crosstalk between Noncoding RNAs and the Epigenetics Machinery in Pediatric Tumors and Their Microenvironment.

Pathania A Cancers (Basel). 2023; 15(10).

PMID: 37345170 PMC: 10216492. DOI: 10.3390/cancers15102833.


Methylation hallmarks on the histone tail as a linker of osmotic stress and gene transcription.

Xiao M, Wang J, Xu F Front Plant Sci. 2022; 13:967607.

PMID: 36035677 PMC: 9399788. DOI: 10.3389/fpls.2022.967607.


H3K9 tri-methylation at Nanog times differentiation commitment and enables the acquisition of primitive endoderm fate.

Dubois A, Vincenti L, Chervova A, Greenberg M, Vandormael-Pournin S, Bourchis D Development. 2022; 149(17).

PMID: 35976266 PMC: 9482333. DOI: 10.1242/dev.201074.

References
1.
Trojer P, Reinberg D . Facultative heterochromatin: is there a distinctive molecular signature?. Mol Cell. 2007; 28(1):1-13. DOI: 10.1016/j.molcel.2007.09.011. View

2.
Bates L, Alves M, Silva J . Auxin-degron system identifies immediate mechanisms of OCT4. Stem Cell Reports. 2021; 16(7):1818-1831. PMC: 8282470. DOI: 10.1016/j.stemcr.2021.05.016. View

3.
Nicetto D, Donahue G, Jain T, Peng T, Sidoli S, Sheng L . H3K9me3-heterochromatin loss at protein-coding genes enables developmental lineage specification. Science. 2019; 363(6424):294-297. PMC: 6664818. DOI: 10.1126/science.aau0583. View

4.
Evsikov A, Graber J, Brockman J, Hampl A, Holbrook A, Singh P . Cracking the egg: molecular dynamics and evolutionary aspects of the transition from the fully grown oocyte to embryo. Genes Dev. 2006; 20(19):2713-27. PMC: 1578697. DOI: 10.1101/gad.1471006. View

5.
Criscione S, Zhang Y, Thompson W, Sedivy J, Neretti N . Transcriptional landscape of repetitive elements in normal and cancer human cells. BMC Genomics. 2014; 15:583. PMC: 4122776. DOI: 10.1186/1471-2164-15-583. View